Lockheed Martin COO St. John sells $2.35M in common stock
Source: Investing.com

Lockheed Martin COO Frank A. St. John sold 3,899 shares on October 23, 2026, for an estimated $2.35 million; his reported direct beneficial ownership afterward was 0.468 shares. The article also cites Q3 2026 EPS of $7.97 versus $7.52 expected and revenue of $20.7 billion versus $20.48 billion expected, with sales up 11% year over year, profit up 15%, and full-year outlook raised. Shares were reported at $622.99, up 13.5% over the past week, while analysts issued mixed rating and price-target changes, including Morgan Stanley’s upgrade to Overweight and targets ranging from $600 to $692.
Analysis
The COO’s sale is a weak standalone signal: without knowing whether it was scheduled, compensation-related, or discretionary, it should not outweigh company-level fundamentals. The reported post-sale direct holding is unusually small, so verify the filing and ownership scope before treating the transaction as a conviction signal. The more actionable tension is momentum versus expectations: after a sharp weekly advance, a strong quarter and raised outlook may already be reflected in price, while analyst targets cited in the report are dispersed. The longer-term case depends less on headline order stability than on whether Lockheed Martin converts production commitments into profitable deliveries and cash; contract economics, supplier capacity, and program execution remain key. A durable production ramp could support suppliers and pressure competitors for defense budgets, but there is not enough evidence here to identify a specific spillover winner. Near term, further estimate revisions could extend the move; over 1–3 months, guidance execution and delivery cadence are the catalysts. Over 6–18 months, margins and cash conversion—not the insider transaction—should determine whether the valuation premium is sustained. Falsifiers are a guidance reduction, weaker-than-expected segment profitability or cash conversion, or evidence that production commitments carry unfavorable economics.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
Key Decisions for Investors
- Do not short LMT solely on this insider sale; first verify the transaction’s plan status and ownership details in the filing.
- Avoid chasing the post-rally move. Existing holders can maintain exposure, but consider adding only after a pullback or confirmation that estimates and delivery cadence continue to improve.
- Track quarterly segment margins, free-cash-flow conversion, and F-35 delivery/contract disclosures; deteriorating execution despite higher sales would invalidate the constructive thesis.
- Treat the next earnings and guidance update as the 1–3 month catalyst; if guidance is cut or cash conversion disappoints, reduce exposure rather than relying on the reported analyst targets.
More News
- Wall Street sees this chip stock as the big winner from the Anthropic IPO
- Manhattan Associates in the spotlight: Cloud growth on trial
- Incyte stock price target maintained at $152 by H.C. Wainwright on cancer drug data
- Broadcom Stock Bounces Back on Upgrade, Anthropic FInancing
- Meta Announces Pricing of Offering of Depositary Shares Representing Series A Mandatory Convertible Preferred Stock and Offering of Class A Common Stock in Connection with Forward Sale Agreements
- Stock Market Today, Oct. 27: Boeing Plummets 11% on Lower Production Rates and Missed Delivery Targets